Arton Baftiu

Arton Baftiu, MPharm, PhD, is currently a Medical Advisor in Oncology at Johnson & Johnson, a role they assumed in 2022. Previously, Arton served as a Medical Advisor in Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2019 to 2022 and held positions as a Scientific Officer in both Pharmacovigilance and Regulatory Affairs at the Norwegian Medicines Agency from 2011 to 2014. They also practiced as a pharmacist at Vitusapotek between 2012 and 2019. Arton earned a PhD in Pharmacoepidemiology and Clinical Pharmacology from Oslo Metropolitan University, where they conducted research on antiepileptic drug utilization and its clinical implications.